Tianxin Pharmaceutical has successfully passed the Korean MFDS certification!

Recently, the company received notification from the Ministry of Food and Drug Safety (MFDS) of Korea that Tianxin Pharmaceutical successfully passed the MFDS GMP on-site inspection and has been registered and publicized on the MFDS website.

This on-site review covered the quality management system, material system, production system, facilities and equipment system, packaging and labeling system, and laboratory control system. A comprehensive and multi-dimensional evaluation of the company was conducted through on-site inspection, review of system documents, random checks of laboratory quality and records, and on-site questioning.

During the review, the MFDS audit expert team highly praised and fully affirmed Tianxin Pharmaceutical's management system, which complies with the requirements of Article 69-5 of the Pharmaceutical Affairs Act and Article 87-3 of the Regulation on Safety of Drugs in Korea.

The successful passing of the Korean MFDS on-site inspection by Tianxin Pharmaceutical not only signifies that its GMP system operates in accordance with Korean GMP standards, providing strong assurance for product quality, but also recognizes the company's years of dedicated efforts in building a quality management system. Looking ahead, this achievement will effectively strengthen the company's cooperation and mutual trust with its South Korean clients, playing a positive role in further expanding the company's business in the South Korean market.

Since its establishment in 2004, Jiangxi Tianxin Pharmaceutical Co., Ltd. has always adhered to the core philosophy of "meticulously crafting products and caring for health with heart," deeply cultivating the cause of human health. With professional R&D capabilities, stringent quality control, and a comprehensive service system, the company continuously empowers people's pursuit of a better life, fulfilling its corporate social responsibility and mission through concrete actions.